Is transhumanism really the world’s most dangerous idea?
By Michael Cook,
Mercatornet
| 07. 20. 2016
In 2004 the editors of the journal Foreign Policy asked several prominent intellectuals to identify the world’s most dangerous idea. Surprisingly political scientist Francis Fukuyama’s choice was transhumanism. He described it as a movement “to liberate the human race from its biological constraints”. Its supporters, he said, want to “wrest their biological destiny from evolution's blind process of random variation and adaptation and move to the next stage as a species”.
Most people would ask, “Are you kidding?” In fact, the transhumanist projects which surface in the media do sound improbable, not to say loopy. Here are three which have been widely reported.
- Elon Musk, the American billionaire boss of Tesla and Space X, recently told a conference of programmers in San Francisco that humans need to augment their brain power with “neural lace”, a fine mesh integrated into the brain which would link the brain directly to the internet. If we fail to keep pace with artificial intelligence, we will become house pets for “ultra-intelligent AI”, he said. “I don’t love the idea of being a house cat,” he...
Related Articles
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...